In-Flight Lab Analysis

In-Flight Lab Analysis

THE CHALLENGE
THE RESEARCH
THE PROGRESS
TECHNICAL DATA


A | A | A

The same diagnostic capabilities that exist in today’s hospitals may soon be available in Space!

The same diagnostic capabilities that exist in today’s hospitals may soon be available in Space!

  • ExMC - Exploration Medical Capabilities

    HRP - Human Research Program

    SBIR - Small Business Innovation Research

In-Flight Lab Analysis Images

X

Measure Lab Analytes

We do not have the capability to measure laboratory analytes in a minimally invasive manner during exploration missions.

Evidence from medical records, spaceflight operations and research findings provides the basis for identifying the most significant human risks in space exploration, including physiological and performance effects from hazards such as altered gravity, radiation, hostile/closed environments, isolation and distance. Each risk is assigned to an HRP Element (divisions of human research) to identify knowledge gaps, or the critical questions that must be answered, in order to mitigate the risk. These gaps become the focus of research conducted to reduce the likelihood and consequence of risks becoming a reality. To learn more about the Risk Identification and Mitigation process and the tasks developed to reduce those risks for the program please click on the link below the gap for more information.
X

Bone Fractures

We do not have the capability to stabilize bone fractures and accelerate fracture healing during exploration missions.

Evidence from medical records, spaceflight operations and research findings provides the basis for identifying the most significant human risks in space exploration, including physiological and performance effects from hazards such as altered gravity, radiation, hostile/closed environments, isolation and distance. Each risk is assigned to an HRP Element (divisions of human research) to identify knowledge gaps, or the critical questions that must be answered, in order to mitigate the risk. These gaps become the focus of research conducted to reduce the likelihood and consequence of risks becoming a reality. To learn more about the Risk Identification and Mitigation process and the tasks developed to reduce those risks for the program please click on the link below the gap for more information.
X

Muscular Injuries

We do not have the capability to optimally treat musculoskeletal injuries during exploration missions.

Evidence from medical records, spaceflight operations and research findings provides the basis for identifying the most significant human risks in space exploration, including physiological and performance effects from hazards such as altered gravity, radiation, hostile/closed environments, isolation and distance. Each risk is assigned to an HRP Element (divisions of human research) to identify knowledge gaps, or the critical questions that must be answered, in order to mitigate the risk. These gaps become the focus of research conducted to reduce the likelihood and consequence of risks becoming a reality. To learn more about the Risk Identification and Mitigation process and the tasks developed to reduce those risks for the program please click on the link below the gap for more information.
X

Pharmacological Efficacy

We do not have the capability to package medications to preserve stability and shelf-life during exploration missions.

Evidence from medical records, spaceflight operations and research findings provides the basis for identifying the most significant human risks in space exploration, including physiological and performance effects from hazards such as altered gravity, radiation, hostile/closed environments, isolation and distance. Each risk is assigned to an HRP Element (divisions of human research) to identify knowledge gaps, or the critical questions that must be answered, in order to mitigate the risk. These gaps become the focus of research conducted to reduce the likelihood and consequence of risks becoming a reality. To learn more about the Risk Identification and Mitigation process and the tasks developed to reduce those risks for the program please click on the link below the gap for more information.
X

Immune Dysregulation

We have not defined and validated a terrestrial human analog for spaceflight-associated immune system dysregulation.

Evidence from medical records, spaceflight operations and research findings provides the basis for identifying the most significant human risks in space exploration, including physiological and performance effects from hazards such as altered gravity, radiation, hostile/closed environments, isolation and distance. Each risk is assigned to an HRP Element (divisions of human research) to identify knowledge gaps, or the critical questions that must be answered, in order to mitigate the risk. These gaps become the focus of research conducted to reduce the likelihood and consequence of risks becoming a reality. To learn more about the Risk Identification and Mitigation process and the tasks developed to reduce those risks for the program please click on the link below the gap for more information.